Please provide your email address to receive an email when new articles are posted on . At diagnosis, the area under the receiver operating characteristic curve in two test sets was 0.92 and 0.88.

CAMBRIDGE, Mass.--(BUSINESS WIRE)--Anumana, a leading AI-driven health technology company and portfolio company of nference, announced a new study that revealed promising results in support of further ...

Screening for a sometimes fatal condition among patients with a rare autoimmune disease could soon - thanks to a computer algorithm - become even more accurate. Researchers at Michigan Medicine found ...

A Mayo Clinic and Janssen-backed venture has received FDA breakthrough designation for an algorithm designed to enable early detection of pulmonary hypertension. Anumana Inc. received the breakthrough ...

Please provide your email address to receive an email when new articles are posted on . Use of the DETECT algorithm was a better screening tool for systemic sclerosis-associated peripheral arterial ...

This transcript has been edited for clarity. Vallerie McLaughlin, MD: Hello. I'm Dr. Vallerie McLaughlin from the University of Michigan. And welcome to this edition of Medscape InDiscussion series on ...

Hypertension is one of the most common chronic conditions in the U.S., affecting nearly half of the country’s adults, according to the Centers for Disease Control and Prevention. Unfortunately, ...

Repurposing drugs can cut down the time and cost of developing treatments for rare diseases, which historically don't receive much investment into research and drug development. Pulmonary hypertension ...

First, we have a diagnostic algorithm for unexplained shortness of breath or suspicion of pulmonary hypertension. And as you just said, when there are signs of severity or when PAH or CTEPH (chronic ...